Related Experiment Video
Updated: Jun 20, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Sequential supramolecular assembly of tannic acid and phenylboronic acid copolymers enabling enhanced cancer
Anudari Batbayar1,2, Ryotaro Ohashi1,2, Yuto Honda1,2,3
1Laboratory for Chemistry and Life Science, Institute of Integrated Research, Institute of Science Tokyo, 4259 Nagatsuta-cho, Midori-ku, Yokohama, Kanagawa, 226-8501, Japan. honda.y.aj@m.titech.ac.jp.
Abstract:
Cancer vaccines elicit responses of cytotoxic T lymphocytes (CTLs) and establish durable immune memory, offering promising cancer therapies. However, soluble tumor-associated antigens (TAAs) alone are rapidly cleared and poorly internalized by antigen-presenting cells (APCs), limiting cross-presentation and antitumor efficacy. Conventional nanoparticle-based delivery systems can prolong antigen retention but are often large (>100 nm), cationic, and cytotoxic, restricting their accumulation in lymph nodes (LNs) and impairing immune function. Here, to overcome these limitations, we report a sequentially self-assembled ternary complex composed of tannic acid (TA) and phenylboronic acid (PBA)-conjugated polymers for antigen delivery. Sequential coating of a protein antigen with TA and PBA-polymers generated a core-shell structure with a diameter of ∼20 nm and a neutral surface charge. Using ovalbumin (OVA) as a model protein antigen, we constructed the OVA-loaded ternary complex, and it exhibited significantly enhanced accumulation in draining LNs and uptake by APCs. Within APCs, PBA-conjugated polymers dissociated from the complex in response to the acidic pH of a late-endosome/lysosome and induced membrane destabilization through the hydrophobicity of deionized PBA and the cationic charge of residual lysine residues, enabling efficient endosomal escape and cross-presentation. Consequently, the ternary complex elicited potent CTL responses and inhibited the growth of OVA-expressing tumors with negligible adverse effects in mouse models. The ternary complex may be a promising antigen delivery platform.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

